Pfizer contributes $4.5M to Alzheimer's research

Guest Contributor
July 5, 2012

Pfizer Canada is contributing $4.5 million to a fund that will support the creation of a consortium of Quebec-based researchers for Alzheimer's disease and support high-risk, high-spinoff projects. The funding goes to the Fonds de recherche du Québec - Santé which will manage the Pfizer-FRQS Innovation Fund for Alzheimer's Disease and Related Disorders. Among its intended outcomes are an Alzheimer's patient data registry and a better understanding of the mechanisms underlying the disease by exploring research hypotheses that have never been tested. Details will be announced later this month on the FRQS website (www.frqs.gouv.qc.ca)....


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.